Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) - Net Assets
Based on the latest financial reports, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has net assets worth $4.99 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.42 Million) and total liabilities ($4.43 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore HKPD total asset value for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.99 Million |
| % of Total Assets | 52.99% |
| Annual Growth Rate | 191.78% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 304.76 |
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Net Assets Trend (2023–2025)
This chart illustrates how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's net assets have evolved over time, based on quarterly financial data. Check HKPD goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2025)
The table below shows the annual net assets of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2025. For live valuation and market cap data, see market cap of Hong Kong Pharma Digital Technology Hold.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $4.99 Million | +17.31% |
| 2024-03-31 | $4.25 Million | +626.82% |
| 2023-03-31 | $585.24K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 646.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.50 Million | 30.14% |
| Common Stock | $11.00K | 0.22% |
| Other Comprehensive Income | $10.82K | 0.22% |
| Other Components | $3.46 Million | 69.42% |
| Total Equity | $4.99 Million | 100.00% |
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Competitors by Market Cap
The table below lists competitors of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Anagenics Ltd
AU:AN1
|
$4.88 Million |
|
Tianci International, Inc. Common Stock
NASDAQ:CIIT
|
$4.88 Million |
|
Samchai Steel Industries Public Company Limited
BK:SAM
|
$4.89 Million |
|
Moolec Science SA Ordinary Shares
NASDAQ:MLEC
|
$4.89 Million |
|
Hansa Investment Company Ltd
LSE:HANA
|
$4.87 Million |
|
Astrotech Corp
NASDAQ:ASTC
|
$4.87 Million |
|
IMPRENDIROMA S.P.A.
F:Y37
|
$4.87 Million |
|
Tantech Holdings Ltd
NASDAQ:TANH
|
$4.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,253,659 to 4,989,769, a change of 736,110 (17.3%).
- Net loss of 27,056 reduced equity.
- New share issuances of 4,300,000 increased equity.
- Other comprehensive income increased equity by 15,677.
- Other factors decreased equity by 3,552,511.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-27.06K | -0.54% |
| Share Issuances | $4.30 Million | +86.18% |
| Other Comprehensive Income | $15.68K | +0.31% |
| Other Changes | $-3.55 Million | -71.2% |
| Total Change | $- | 17.31% |
Book Value vs Market Value Analysis
This analysis compares Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.91x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 8.33x to 0.91x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-03-31 | $0.05 | $0.44 | x |
| 2024-03-31 | $0.58 | $0.44 | x |
| 2025-03-31 | $0.49 | $0.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.13%
- • Asset Turnover: 2.16x
- • Equity Multiplier: 1.89x
- Recent ROE (-0.54%) is below the historical average (67.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | 170.56% | 7.95% | 3.69x | 5.82x | $939.67K |
| 2024 | 31.26% | 7.97% | 1.93x | 2.04x | $904.35K |
| 2025 | -0.54% | -0.13% | 2.16x | 1.89x | $-526.03K |
Industry Comparison
This section compares Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $3,366,678,585
- Average return on equity (ROE) among peers: -18.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) | $4.99 Million | 170.56% | 0.89x | $4.87 Million |
| Bimi International Medical Inc (BIMI) | $27.30 Million | -5.75% | 0.52x | $1.40K |
| High Tide Inc (HITI) | $23.32 Million | -19.39% | 0.11x | $186.34 Million |
| PetMed Express Inc (PETS) | $97.00 Million | 21.52% | 0.10x | $41.73 Million |
| POMDOCTOR LIMITED American Depositary Shares (POM) | $-309.35 Million | 0.00% | 0.00x | $17.65 Million |
| Ridgetech, Inc. (RDGT) | $14.36 Million | -176.53% | 2.20x | $683.17K |
| Scienture Holdings, Inc. (SCNX) | $-18.51K | 0.00% | 0.00x | $13.53 Million |
| SunLink Health Systems Inc (SSY) | $42.39 Million | 2.15% | 1.53x | $7.85 Million |
| Walgreens Boots Alliance Inc (WBA) | $30.41 Billion | 14.26% | 1.96x | $10.37 Billion |
| Wellgistics Health, Inc. Common Stock (WGRX) | $-2.90 Million | 0.00% | 0.00x | $7.62 Million |
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The comp… Read more